Trials / Completed
CompletedNCT00192374
Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Children
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Phase III, Multicenter Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B,Live, Cold-Adapted (CAIV-T) in Healthy Children
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,920 (planned)
- Sponsor
- MedImmune LLC · Industry
- Sex
- All
- Age
- 6 Months – 35 Months
- Healthy volunteers
- Accepted
Summary
\- Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of(CAIV-T) in Healthy Children.
Detailed description
\- A Prospective, Randomized, Double-Blind, Placebo-Controlled, Phase III, Multicenter Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A \& B, Live Cold-Adapted (CAIV-T) in Healthy Children
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CAIV-T, Liquid |
Timeline
- Start date
- 2002-02-01
- Completion
- 2002-11-01
- First posted
- 2005-09-19
- Last updated
- 2006-10-03
Locations
2 sites across 2 countries: Philippines, Thailand
Source: ClinicalTrials.gov record NCT00192374. Inclusion in this directory is not an endorsement.